Xian Lu

2.8k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Xian Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Xian Lu has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Xian Lu's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (7 papers). Xian Lu is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (7 papers). Xian Lu collaborates with scholars based in United States, Canada and China. Xian Lu's co-authors include D. Ross Camidge, Robert C. Doebele, Anna E. Barón, Dara L. Aisner, Andrew Weickhardt, Paul A. Bunn, Joseph Burke, Gregory N. Gan, Brian D. Kavanagh and Laurie E. Gaspar and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xian Lu

38 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

2012 508 citations Andrew Weickhardt, Xian Lu et al. Journal of Thoracic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xian Lu United States	20	1.3k	1.1k	642	454	134	39	1.9k
Kenji Tomizawa Japan	26	1.5k 1.1×	1.3k 1.1×	874 1.4×	393 0.9×	288 2.1×	72	2.4k
Haruhiro Yukiue Japan	29	1.1k 0.8×	812 0.7×	839 1.3×	352 0.8×	174 1.3×	71	2.0k
Kadoaki Ohashi Japan	21	1.8k 1.4×	1.7k 1.5×	880 1.4×	541 1.2×	170 1.3×	135	2.5k
Soji Kakiuchi Japan	21	910 0.7×	850 0.8×	998 1.6×	313 0.7×	98 0.7×	41	1.9k
Felice Mucilli Italy	16	1.5k 1.1×	1.1k 1.0×	756 1.2×	464 1.0×	183 1.4×	59	2.0k
Jacqui Rowbottom United Kingdom	10	791 0.6×	1.2k 1.1×	567 0.9×	321 0.7×	89 0.7×	14	1.6k
Kazumi Nishino Japan	25	1.6k 1.2×	1.4k 1.2×	661 1.0×	735 1.6×	127 0.9×	164	2.3k
Francisco Sánchez-Vega United States	20	756 0.6×	778 0.7×	768 1.2×	481 1.1×	145 1.1×	59	1.7k
Yoshio Tomizawa Japan	24	991 0.7×	1.1k 1.0×	1.1k 1.7×	383 0.8×	118 0.9×	72	2.2k
Anna Maria Rachiglio Italy	20	544 0.4×	819 0.7×	575 0.9×	607 1.3×	131 1.0×	43	1.5k

Countries citing papers authored by Xian Lu

Since Specialization

Citations

This map shows the geographic impact of Xian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian Lu more than expected).

Fields of papers citing papers by Xian Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian Lu. The network helps show where Xian Lu may publish in the future.

Co-authorship network of co-authors of Xian Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xian Lu. A scholar is included among the top collaborators of Xian Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xian Lu. Xian Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Xian, Ruihan Liu, Muhammad Mobeen Tahir, et al.. (2024). In vitro slow-growth conservation, acclimatization, and genetic stability of virus-free apple plants. SHILAP Revista de lepidopterología. 2(1). 2 indexed citations

Liu, Xi, Xi Zhang, Dongxu Wang, et al.. (2024). A Neural Circuit From Paraventricular Nucleus of the Thalamus to the Nucleus Accumbens Mediates Inflammatory Pain in Mice. Brain and Behavior. 15(1). e70218–e70218. 1 indexed citations

Sherry, Alexander D., Cara Haymaker, Tharakeswara Bathala, et al.. (2023). Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). S33–S34. 1 indexed citations

Lu, Xian, et al.. (2022). Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers. BMC Cancer. 22(1). 513–513. 4 indexed citations

Lu, Xian, et al.. (2021). Prognostic value and cost benefit of HPV testing for oropharyngeal cancer patients. Oral Diseases. 29(2). 483–490. 8 indexed citations

Lu, Xian, et al.. (2018). Plasma-Derived Inflammatory Proteins Predict Oral Squamous Cell Carcinoma. Frontiers in Oncology. 8. 585–585. 17 indexed citations

Noonan, Sinéad, Tejas Patil, Dexiang Gao, et al.. (2017). Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung. Journal of Thoracic Oncology. 13(1). 134–138. 19 indexed citations

Hughesman, Curtis, Xian Lu, Yuqi Zhu, et al.. (2017). Detection of clinically relevant copy number alterations in oral cancer progression using multiplexed droplet digital PCR. Scientific Reports. 7(1). 11855–11855. 10 indexed citations

Noonan, Sinéad, Lynne D. Berry, Xian Lu, et al.. (2016). Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis. Journal of Thoracic Oncology. 11(8). 1293–1304. 126 indexed citations

10.

Hughesman, Curtis, et al.. (2016). A Robust Protocol for Using Multiplexed Droplet Digital PCR to Quantify Somatic Copy Number Alterations in Clinical Tissue Specimens. PLoS ONE. 11(8). e0161274–e0161274. 35 indexed citations

11.

McCoach, Caroline E., Eamon M. Berge, Xian Lu, Anna E. Barón, & D. Ross Camidge. (2015). A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry. Journal of Thoracic Oncology. 11(3). 407–413. 43 indexed citations

12.

Nasarre, Patrick, Robert M. Gemmill, Vincent Potiron, et al.. (2013). Neuropilin-2 Is Upregulated in Lung Cancer Cells during TGF-β1–Induced Epithelial–Mesenchymal Transition. Cancer Research. 73(23). 7111–7121. 55 indexed citations

13.

Guin, Sunny, Yuanbin Ru, Murry W. Wynes, et al.. (2013). Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression. Journal of Thoracic Oncology. 8(12). 1492–1501. 39 indexed citations

14.

Cittelly, Diana M., Irina Dimitrova, Erin N. Howe, et al.. (2012). Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel. Molecular Cancer Therapeutics. 11(12). 2556–2565. 104 indexed citations

15.

Weickhardt, Andrew, Robert C. Doebele, Ana B. Oton, et al.. (2012). A Phase I/II Study of Erlotinib in Combination with the Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody IMC-A12 (Cixutumumab) in Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 7(2). 419–426. 46 indexed citations

16.

Doebele, Robert C., Xian Lu, Christopher Sumey, et al.. (2012). Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer. Cancer. 118(18). 4502–4511. 223 indexed citations

17.

Christoph, Daniel C., Bernadette Reyna Asuncion, Céline Mascaux, et al.. (2012). Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 7(9). 1440–1448. 34 indexed citations

18.

Camidge, D. Ross, Scott A. Kono, Xian Lu, et al.. (2011). Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed. Journal of Thoracic Oncology. 6(4). 774–780. 195 indexed citations

19.

Wang, Xiaotian, Fang Zhang, John I. Song, et al.. (2011). Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncology. 48(1). 73–78. 71 indexed citations

20.

Yao, Lei, et al.. (2008). Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats. Basic Research in Cardiology. 104(3). 258–268. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact